Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,159 | -11,016 | -6,128 | -41 | -2,771 |
| Depreciation Amortization | 8,854 | 35,029 | 25,975 | 16,474 | 7,365 |
| Income taxes - deferred | N/A | -1,828 | N/A | N/A | N/A |
| Accounts receivable | 8,542 | -8,524 | -3,567 | -2,141 | -1,766 |
| Accounts payable and accrued liabilities | 2,868 | -1,822 | 829 | -1,321 | -1,442 |
| Other Working Capital | -23,381 | 9,730 | -4,647 | -5,545 | -8,529 |
| Other Operating Activity | 1,166 | 48,951 | 32,154 | 18,836 | 10,642 |
| Operating Cash Flow | $6,208 | $70,520 | $44,616 | $26,262 | $3,499 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -1,622 | N/A | -141,960 | 80,499 |
| PPE Investments | -6,724 | -10,159 | -5,662 | -4,070 | -2,018 |
| Net Acquisitions | N/A | -117,691 | -118,683 | -118,683 | N/A |
| Purchase Of Investment | -72,610 | -318,484 | -221,713 | -1,622 | N/A |
| Sale Of Investment | 50,768 | 319,468 | 248,365 | 163,017 | N/A |
| Investing Cash Flow | $-28,566 | $-128,488 | $-97,693 | $-103,318 | $78,481 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -571 | -571 | -571 | -338 |
| Common Stock Issued | 3,455 | 10,871 | 6,261 | 4,838 | 1,101 |
| Other Financing Activity | -4,736 | -6,630 | 0 | 0 | -233 |
| Financing Cash Flow | $-1,281 | $3,670 | $5,690 | $4,267 | $530 |
| Beginning Cash Position | 78,228 | 132,526 | 132,526 | 132,526 | 132,526 |
| End Cash Position | 54,589 | 78,228 | 85,139 | 59,737 | 215,036 |
| Net Cash Flow | $-23,639 | $-54,298 | $-47,387 | $-72,789 | $82,510 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,208 | 70,520 | 44,616 | 26,262 | 3,499 |
| Capital Expenditure | -6,724 | -10,159 | -5,662 | -4,070 | -2,018 |
| Free Cash Flow | -516 | 60,361 | 38,954 | 22,192 | 1,481 |